Literature DB >> 10457264

Modulation of osteoblast-like cell behavior by activation of protease-activated receptor-1.

L A Abraham1, E J MacKie.   

Abstract

In addition to playing a central role in thrombosis and hemostasis, the serine protease thrombin is a specific agonist for a variety of functional responses in cells including osteoblast-like cells. Many of the cellular responses to thrombin are mediated by protease-activated receptor-1 (PAR-1). Since osteoblasts express PAR-1 in vivo during development, the effect of PAR-1 activation on proliferation and differentiation in primary rat osteoblast-like cells was investigated. Thrombin or the rat PAR-1-activating peptide SFFLRNPSENTFELVPL (SFFL) stimulated cell proliferation (as assessed by 3H- thymidine incorporation) of primary osteoblast-like cells derived from long bone or calvaria, and treatment with antibodies to PAR-1 abolished the proliferative response to thrombin. Activation of PAR-1 by thrombin or SFFL inhibited endogenous alkaline phosphatase (ALP) activity and caused a transient elevation of intracellular calcium in the osteoblast-like cells. Calcium mobilization was not, however, required for thrombin's effect on proliferation or ALP activity. The ability of a number of growth factors and hormones to regulate expression of PAR-1 in osteoblast-like cells was investigated. Expression of PAR-1 transcript and protein by osteoblast-like cells in vitro was markedly increased by treatment with transforming growth factor-beta (TGF-beta), and the proliferative response to thrombin was enhanced by TGF-beta pretreatment. Platelet-derived growth factor-BB caused a slight but significant down-regulation of PAR-1 mRNA expression. Thrombin caused a transient increase in PAR-1 expression, whereas neither parathyroid hormone-related peptide nor 1, 25-dihydroxyvitamin D3 had any effect. The observations described here suggest that PAR-1 mediates thrombin-induced osteoblast proliferation, which in turn may contribute to responses of osteoblasts to osteogenic growth factors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10457264     DOI: 10.1359/jbmr.1999.14.8.1320

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  9 in total

1.  Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.

Authors:  Sandra Jastrzebski; Judith Kalinowski; Sehwan Mun; Bongjin Shin; Naga Suresh Adapala; Christian E Jacome-Galarza; Faryal Mirza; H Leonardo Aguila; Hicham Drissi; Archana Sanjay; Ernesto Canalis; Sun-Kyeong Lee; Joseph A Lorenzo
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

2.  Divergent upstream osteogenic events contribute to the differential modulation of MG63 cell osteoblast differentiation by MMP-1 (collagenase-1) and MMP-13 (collagenase-3).

Authors:  Takayuki Hayami; Yvonne L Kapila; Sunil Kapila
Journal:  Matrix Biol       Date:  2011-04-22       Impact factor: 11.583

3.  The role of protease-activated receptor-1 in bone healing.

Authors:  Shu Jun Song; Charles N Pagel; Therese M Campbell; Robert N Pike; Eleanor J Mackie
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

Review 4.  Relationship between heterotopic ossification and traumatic brain injury: Why severe traumatic brain injury increases the risk of heterotopic ossification.

Authors:  Huan Huang; Wen-Xiang Cheng; Yi-Ping Hu; Jian-Hai Chen; Zheng-Tan Zheng; Peng Zhang
Journal:  J Orthop Translat       Date:  2017-11-14       Impact factor: 5.191

Review 5.  Role of Thrombin in Central Nervous System Injury and Disease.

Authors:  Nathan A Shlobin; Meirav Har-Even; Ze'ev Itsekson-Hayosh; Sagi Harnof; Chaim G Pick
Journal:  Biomolecules       Date:  2021-04-12

Review 6.  Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines.

Authors:  Madison J Petkovic; Huyen A Tran; Peter R Ebeling; Ayse Zengin
Journal:  Haemophilia       Date:  2022-03-15       Impact factor: 4.263

7.  Osteogenesis in human periodontal ligament stem cell sheets is enhanced by the protease-activated receptor 1 (PAR1) in vivo.

Authors:  Tomaz Alves; Letícia M Gasparoni; Danilo Balzarini; Emmanuel Albuquerque-Souza; Victhor de Oliveira; Emanuel S Rovai; Jose da Silva; Aldrin Huamán-Mendoza; Luiz H Catalani; Carla R Sipert; Marinella Holzhausen
Journal:  Sci Rep       Date:  2022-09-18       Impact factor: 4.996

8.  The effect of oral dabigatran etexilate on bone density, strength, and microstructure in healthy mice.

Authors:  Mikkel Bo Brent; Jesper Skovhus Thomsen; Annemarie Brüel
Journal:  Bone Rep       Date:  2017-12-18

9.  Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).

Authors:  Emily A Larson; Hillary J Larson; Jason A Taylor; Robert F Klein
Journal:  Calcif Tissue Int       Date:  2021-06-12       Impact factor: 4.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.